Kent Lake Capital LLC Trans Medics Group, Inc. Transaction History

Kent Lake Capital LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$70.86 - $89.93 $1.77 Million - $2.25 Million	-25,000 Reduced 45.45%	30,000 $2.22 Million
Q4 2023 Feb 14, 2024	SELL	$36.74 - $81.08 $2.36 Million - $5.2 Million	-64,129 Reduced 53.83%	55,000 $4.34 Million
Q2 2023 Aug 14, 2023	BUY	$66.23 - $88.73 $942,386 - $1.26 Million	14,229 Added 13.56%	119,129 $10 Million
Q1 2023 May 15, 2023	SELL	$53.63 - $82.33 $7.78 Million - $11.9 Million	-145,100 Reduced 58.04%	104,900 $7.94 Million
Q3 2022 Nov 14, 2022	SELL	$31.56 - $55.75 $4.73 Million - $8.36 Million	-150,000 Reduced 37.5%	250,000 $10.4 Million
Q2 2022 Aug 15, 2022	BUY	$20.56 - $32.15 $4.11 Million - $6.43 Million	200,000 Added 100.0%	400,000 $12.6 Million
Q1 2022 May 16, 2022	BUY	$12.58 - $26.94 $2.52 Million - $5.39 Million	200,000 New	200,000 $5.39 Million

388

31.4M

465K

286K

Ticker TMDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 31,831,400
Market Cap $2.31B
Description
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...

Get notified when there are updates to the investment portfolio of Kent Lake Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Kent Lake Capital LLC with notifications on news.